UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Shares of eye drops/masks makers rise on fine dust measure
Shares of manufacturers of eye drops and masks have risen on Monday, with t...
by Nam Doo-hyun
|
2018-01-15 15:48
라인
Hanmi 1st for R&D investment among Korean pharmas
Hanmi Pharmaceuticals invested the most in research and development among K...
by Marian Chu
|
2018-01-15 15:22
라인
Competition heats up in hair loss treatment market
Local drugmakers are increasingly competing to sell over-the-counter (OTC) ...
by So Jae-hyeon
|
2018-01-15 15:02
라인
'Postmenopausal use of aromatase inhibitor ups fracture risk’
The postmenopausal use of aromatase inhibitor (AI) on breast cancer patient...
by Nam Doo-hyun
|
2018-01-15 14:42
라인
Hepatitis C drug Mavyret arrives in Korea
Abbvie’s hepatitis C treatment Mavyret (ingredient: glecaprevir/pibrentasvi...
by Lee Hye-seon
|
2018-01-15 11:19
라인
Gaucher disease drug effective for retention, early treatment, Sanofi says
Sanofi Genzyme emphasized the convenience of Cerdelga (Ingredient: eligusta...
by Nam Doo-hyun
|
2018-01-15 10:27
라인
AstraZeneca gets expanded FDA approval for cancer drug
The U.S. Food and Drug Administration said Friday it approved AstraZeneca’s...
by Marian Chu
|
2018-01-15 10:20
라인
Why is mental health treatment sluggish in Korea?
Shock rippled through Korea when Jong-hyun, a talented, prolific K-pop star...
by Marian Chu
|
2018-01-12 17:37
라인
FDA warns against possible link between death and feeding tubes
The U.S. Food and Drug Administration (FDA) issued a safety alert regarding...
by Lee Han-soo
|
2018-01-12 16:21
라인
Newborns died of Citrobacter sepsis: police
The cause of deaths of the four newborns at Ewha Womans University Hospital...
by Kwak Sung-sun
|
2018-01-12 14:50
라인
Ministry issues cold-related illness advisory
The Korea Centers for Disease Control and Prevention (KCDC) advised the pub...
by Lee Han-soo
|
2018-01-12 14:36
라인
Government bans dihydrocodeine for children under 12
The Ministry of Food and Drug Safety has banned the use of dihydrocodeine-c...
by Lee Hye-seon
|
2018-01-12 14:35
라인
Lawmaker motions bill for approving use of medical marijuana in Korea
A lawmaker has set out to revise the current laws against marijuana to allo...
by Marian Chu
|
2018-01-11 18:02
라인
Korean triplets born 2 months apart for 1st time, SNUH says
A 35-year-old Korean mother has given birth to triplets two months apart, t...
by Marian Chu
|
2018-01-11 17:06
라인
Daewoong gets approval to start Nabota BTX clinical trials in China
Daewoong Pharmaceutical is making inroads into the Chinese market with its ...
by Marian Chu
|
2018-01-11 16:24
라인
Drugmakers work on ‘me-too’ drugs of Pradaxa
Hanmi Pharmaceutical, Ahngook Pharmaceutical, Dasan Medichem, and Huons are...
by Lee Hye-seon
|
2018-01-11 16:12
라인
Hanmi slates US-based phase 1 trial for LAPSTriple Agonist: CEO
Hanmi Pharmaceutical is ramping up efforts to enter the global market with ...
by Marian Chu
|
2018-01-11 15:59
라인
Korean drugmakers promote pipelines at JP Morgan event
Korean pharmaceutical and biotech firms publicized their competitiveness, u...
by So Jae-hyeon
|
2018-01-11 15:42
라인
Drugmakers speed up ownership successions
Since the beginning of the New Year, pharmaceutical companies are accelerat...
by So Jae-hyeon
|
2018-01-11 12:01
라인
AstraZeneca gets go-ahead for biologic asthma drug in Europe
AstraZeneca and its global research and development subsidiary MedImmune sa...
by Marian Chu
|
2018-01-11 10:48
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top